Today's Top Stories | | By Sam Quirke | June 17, 2026 11:05 AM |
| | | By Chris Markoch | June 17, 2026 10:30 AM |
| | By Jeffrey Neal Johnson | June 17, 2026 09:55 AM |
| | | By Jeffrey Neal Johnson | June 17, 2026 08:10 AM |
| | By Ryan Hasson | June 16, 2026 10:05 AM |
|
|
 | Top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)Analyst Ross Givens says the top AI opportunity right now isn't Microsoft, Google, Amazon, Apple, or Nvidia - it's a small, under-the-radar stock trading for just a few dollars.
This company holds 98 registered patents in voice and sound recognition technology and has secured partnerships with Honda, Netflix, Pandora, and Mercedes-Benz.
Get the full details on this under-the-radar AI stock now |
|
Analysts' Upgrades | | Lyft (NASDAQ:LYFT) was upgraded by Rothschild & Co Redburn from "neutral" to "buy". They now have a $22.00 price target on the stock. This represents a 53.0% upside from the current price of $14.38. | | Macerich (NYSE:MAC) was upgraded by JPMorgan Chase & Co. from "underweight" to "neutral". They now have a $25.00 price target on the stock, up from $23.00. This represents a 6.7% upside from the current price of $23.43. | | Prima BioMed (NASDAQ:IMMP) was upgraded by Maxim Group from "hold" to "buy". The current price is $0.38. | | uniQure (NASDAQ:QURE) was upgraded by Cantor Fitzgerald from "neutral" to "overweight". They now have a $61.00 price target on the stock. This represents a 29.2% upside from the current price of $47.21. | | Wabash National (NYSE:WNC) was upgraded by DA Davidson from "neutral" to "buy". They now have a $20.00 price target on the stock. This represents a 79.5% upside from the current price of $11.14. |
|
View More Upgrades
|
Analysts' Downgrades | | Rexford Industrial Realty (NYSE:REXR) was downgraded by JPMorgan Chase & Co. from "neutral" to "underweight". They now have a $36.00 price target on the stock, down from $38.00. This represents a 8.0% upside from the current price of $33.34. |
|
View More Downgrades
|
They told you not to miss this one (Ad)The largest companies in the SP 500 are now more overvalued relative to fundamentals than they were at the absolute peak of the dot-com era. An MIT study found that 95% of companies investing in AI are seeing zero measurable return - yet the spending continues.
OpenAI CEO Sam Altman has publicly said investors are 'overexcited' about AI. The investors who survived the dot-com crash weren't the ones who called the bottom - they were the ones who weren't fully exposed when it happened.
Thor Metals Group offers a free guide on building a retirement not tied to this bet.
Get your free guide from Thor Metals Group and protect your retirement |
|
Analysts' New Coverage | | BrightView (NYSE:BV) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $17.00 price target on the stock. This represents a 31.5% upside from the current price of $12.93. | | Fervo Energy (NASDAQ:FRVO) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $47.00 price target on the stock. This represents a 29.0% upside from the current price of $36.43. | | Global Medical REIT (NYSE:XRN) is now covered by Raymond James Financial, Inc.. They set a "market perform" rating on the stock. The current price is $35.30. | | Healthpeak Properties (NYSE:DOC) is now covered by Raymond James Financial, Inc.. They set a "market perform" rating on the stock. The current price is $19.84. | | Sabra Healthcare REIT (NASDAQ:SBRA) is now covered by Raymond James Financial, Inc.. They set an "underperform" rating on the stock. The current price is $18.13. | | Tyra Biosciences (NASDAQ:TYRA) is now covered by JonesTrading. They set a "buy" rating and a $56.00 price target on the stock. This represents a 93.2% upside from the current price of $28.99. | | Western Midstream Partners (NYSE:WES) is now covered by Mizuho. They set an "outperform" rating and a $48.00 price target on the stock. This represents a 10.3% upside from the current price of $43.51. |
|
View More New Coverage
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
|
![History is About to Be Made... [Last Big Wealth Opportunity For a Decade]](https://www.marketbeat.com/logos/videos/small_20260616172403_videomakemillionares-play.png)
